Pathophysiology of chemical injury of the thyroid gland

C C Capen1

  • 1Department of Veterinary Pathobiology, Ohio State University, Columbus 43210.

Toxicology Letters
|December 1, 1992
PubMed

Insights

Many chemicals and physiological changes can disrupt thyroid hormone production, leading to increased thyroid tumors in rodents. Chronic overstimulation by thyroid-stimulating hormone (TSH) is a key factor in this process.

Area of Science:

  • Toxicology
  • Endocrinology
  • Oncology

Background:

  • Goitrogenic xenobiotics and physiological changes can disrupt thyroid hormone biosynthesis, secretion, and metabolism.
  • These disruptions can lead to increased thyroid-stimulating hormone (TSH) levels and thyroid follicular cell proliferation.
  • Chronic TSH stimulation is a significant risk factor for thyroid tumor development in rodents.

Purpose of the Study:

  • To review the mechanisms by which goitrogenic substances and physiological perturbations disrupt thyroid hormone economy.
  • To highlight the role of chronic TSH hypersecretion in rodent thyroid oncogenesis.

Main Methods:

  • Review of literature on goitrogens and their effects on thyroid hormone homeostasis.
  • Analysis of mechanisms affecting iodine uptake, hormone synthesis, secretion, and peripheral metabolism.
  • Examination of the link between disrupted thyroid hormone economy and thyroid tumor incidence in rodent studies.

Main Results:

  • Goitrogens disrupt thyroid function through direct effects on hormone synthesis/secretion or by increasing peripheral hormone metabolism.
  • Inhibition of 5'-monodeiodinase reduces T3 levels, leading to compensatory TSH increase.
  • Both xenobiotics and physiological perturbations consistently result in chronic TSH hypersecretion.

Conclusions:

  • Chronic TSH hypersecretion is a common pathway for thyroid tumorigenesis induced by various goitrogens in rodents.
  • Understanding these mechanisms is crucial for assessing the carcinogenic potential of xenobiotics affecting the thyroid gland.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...